Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Marksans Pharma: Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue Of Convertible Warrants.
News Announcement

Marksans Pharma: Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue Of Convertible Warrants.

09-Nov-2023 Follow Value Research Online on Google download pdfDownload PDF Marksans Pharma

Pursuant to regulation 32 of LODR Please find enclosed a NIL statement of Deviation reviewed by audit committee for quarter ended September 30 2023

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.